Method for improving pharmacokinetics
US10918626B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 8, 2020 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | Apr 8, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The object of the present invention is to inhibit oxidative metabolism of a compound of formula I by co-administration with ritonavir, a cytochrome P450 inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.